T. Yamaoka et al., Apoptosis and remodelling of beta cells by paracrine interferon-gamma without insulitis in transgenic mice, DIABETOLOG, 42(5), 1999, pp. 566-573
Aims/hypothesis. To examine whether interferon-gamma destroys islet beta ce
lls directly or indirectly through lymphocyte activation, or whether direct
action of interferon-gamma on beta cells by itself induces diabetes withou
t insulitis.
Methods. To avoid possible nonspecific breakdown of beta cells by transgeni
c overexpression of interferon-gamma by the insulin promoter, we generated
transgenic mice expressing interferon-gamma under the control of rat glucag
on promoter (RGP-IFN-gamma-Tg mice).
Results. The absence of insulitis in RGP-IFN-y-Tg mice enabled us to invest
igate the direct effects of paracrine interferon-gamma. In RCP-IFN-gamma-Tg
mice, se rum concentrations of interferon-gamma and tumour necrosis factor
-alpha (TNF-alpha) were 50 and 6 times higher than those in their littermat
es, respectively, and glucose-responsive insulin secretion decreased to one
-half the level of that in the littermates. Transgenic interferon-gamma ind
uced remodelling of beta cells where apoptosis of many beta cells was compe
nsated by their vigorous regeneration and diabetes did not occur in most of
the RG-IFN-gamma-Tg mice.
Conclusion/interpretation. Interferon-gamma alone is insufficient for the c
omplete destruction of beta cells in vivo, and factors other than interfero
n-gamma including activated lymphocytes or other cytokines, are necessary i
n addition to interferon-gamma for the development of Type I (insulin-depen
dent) diabetes mellitus.